Navigation Links
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Date:11/24/2008

Company reaffirms its innovation leadership and long-term commitment to hepatitis research

KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today provided a clinical update on boceprevir, its lead investigational oral hepatitis C protease inhibitor currently in Phase III development. The company believes boceprevir has the potential to be a first-in-class and best-in-class protease inhibitor for treating chronic hepatitis C. The company also announced that it is developing a highly potent next-generation oral hepatitis C protease inhibitor that has future best-in-class potential. The compound, known as SCH 900518 is currently in Phase IIa clinical development. The update was presented today as part of the company's 2008 R&D Update meeting at its headquarters in Kenilworth, N.J.

"As pioneers in the hepatitis field, our vision is to apply our experience and innovation, as we have in the past, to continue to redefine and improve treatments for chronic hepatitis C, in the near term and in the future," said Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute.

The company reported for the first time that in a Phase II study, a 48-week boceprevir regimen achieved an unprecedented 75 percent sustained virologic response (SVR) rate at 24 weeks after the end of treatment (SVR 24) in patients who received 4 weeks of PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) prior to the addition of boceprevir (800 mg TID) (P/R lead-in). This represents a near doubling of the 38 percent SVR 24 rate for patients in the control group receiving 48-weeks of PEGINTRON and REBETOL alone (ITT).(1,2) In a 28-week boceprevir P/R lead-in regimen, the SVR 24 rate was 56 percent. Importantly, for patients who received
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
2. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
3. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
4. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
5. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
6. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
7. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
8. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
9. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
10. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
11. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RGH,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens,aBe...anautoaccident,wasactuallyfullyconsciousandawakedu...egment.TheDynaVoxEyeMaxwasfeaturedinthesegmenttoil...itionscanunlockcommunication. ,, WHEN:GoodMorni... www.dynavoxtech.com ,, WHO:RomHoubenswasa...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--Vermillion,I...ditsPlanofReorganizationandDisclosureStatementtoda...rtfortheDistrictofDelaware.Ahearingtoconsiderappro...December8,2009,withthehearingontheconfirmationofth...fortheCompanytopayallclaimsinfull.ThePlanisexpecte...
(Date:11/24/2009)...,Md.,Nov.24/PRNewswire/--Inadditiontofamily,friend...adelphiajurorstoherThanksgivinggratitudelist. ,...kfultothem,"shesaidofMonday,sverdictstotaling$103m...Wisneskiisamong12,000womennationwidewhohavesuedWye...pydrugsPremarinandPrempro.Wisneskiandtheothervicti...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Mother 26 Daughter Celebrate Victory Over Meth 53930 1Mother 26 Daughter Celebrate Victory Over Meth 53930 2Prix Galien USA Announces 2009 Final Candidates 13441 1Prix Galien USA Announces 2009 Final Candidates 13441 2X4 Labs to Create Solid Gold Male Enhancement Device for Rich Saudi Man 53926 1X4 Labs to Create Solid Gold Male Enhancement Device for Rich Saudi Man 53926 2
...haVax, Inc.,recently received notification from th...iseases (NIAID), one of the granting institutes of...has been awarded a second grant to,continue develo...oprietary,vector platform. The grant will support ...tes to further characterize the high-level protect...
...ed,this week for its efforts to eliminate cervical...in Hanoi, Vietnam. CEO Peer Schatz came to this,pr...other leaders in,business, NGOs and governments to...-free world., "Nearly 500,000 women around the wo...- a shocking number considering that it,s a highly...
Other Medicine Technology:AlphaVax Continues to Expand the Use of Its Vaccine Platform 2Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders 2Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders 3
(Date:11/25/2009).../PRNewswire/--TheBartleHallConventionCenterwilltem....9-10,whenKansasCityhoststhelatestinaseriesofmassi...iniceventhasthepotentialtobethebiggestoneyet,becau...onweekdaysinsteadofoveraweekend,"SheriWood,executi...entoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...25/PRNewswire/--Thanksgivingmealswillbedeliveredto...BeachareathankstoFaithInAction/VolunteerActionforA...visionofSCANHealthPlan.Formorethan17yearstheseorga...warmThanksgivingmealstoseniorsinneedinLongBeach,La...undingcities. ,, "Ourwarmholidaymealsaredeliver...
(Date:11/25/2009)...ements,Business,andPressJoinEfforttoEducate ,,...again,theNationalBipolarFoundationandtheMedicAlert...tilStable"program,whichisnowbeingwidelyacceptedasa...y,theNationalBipolarFoundationreceivedaproclamatio...Lt.GovernorofLouisianaMitchLandrieu.TheNationalBip...
(Date:11/25/2009)...pressure? This simple question has been the focus...elated gene Modulates High Blood Pressure in Mice ... simple question has been the focus of intense res...e first time established a link between a novel ge...stress in mice as well as humans. The studies were...
(Date:11/25/2009)...lead mothers to overlook needed care, study finds ...-- A mother,s depression can worsen her child,s as...month study of 262 black mothers and their childre...ssive symptoms had more frequent asthma symptoms, ...mptoms had less frequent asthma symptoms. , The...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Mom's Depression May Worsen Child's Asthma 2
...Just like those absconders chased by police all ov...deeds but none really knows how to recognize them....d in the Proceedings of the National Accademy of ... Sangiorgi, we now know how to reveal the stem cel...
...s management sessions prior to and immediately aft...fit for men undergoing a radical prostatectomy for...h from The University of Texas M. D. Anderson Canc... for prostate cancer patients prior to surgery. It...
... Data confirm model can drive fundamental change... Washington, D.C. (Vocus) April 6, 2009 --...C) released today by the American Pharmacists Ass...ealth care costs., , , , ,The data, which will be ...
... of pediatric obesity epidemic and evolving approa... R.I., April 6 A study by CVS Caremark (NYSE: C...rchives of Pediatrics and Adolescent Medicine , fo...ng children increased 15.2%. Observed changes in ...
...low-sugar regimen reduced risk factors , ...iber intake and reducing sugar consumption can hel...ens, a new study shows. , "Latino children are mor...xamined the effects of a high-fiber, low-sugar die...
...ll men getting same screenings as healthy folks, ,...pite clear guidelines recommending that older peop...ive at least four more years, a new study reveals ...s the experiences of men seeking care from a U.S. ...
Other Medicine News:Health News:New technique invented to reveal pancreatic stem cells 2Health News:New technique invented to reveal pancreatic stem cells 3Health News:M. D. Anderson study finds pre-surgical stress management improves mood, quality of life 2Health News:M. D. Anderson study finds pre-surgical stress management improves mood, quality of life 3Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 2Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 3Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 4Health News:Diabetes Ten City Challenge Reduces Health Care Costs and Improves Patient Health 5Health News:CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents 2Health News:CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents 3Health News:Dietary Changes Shield Latino Teens From Diabetes 2Health News:Colon Screenings Don't Follow Guidelines, Study Suggests 2Health News:Colon Screenings Don't Follow Guidelines, Study Suggests 3
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: